Oxford Biomedica signs development & supply agreement with Boehringer Ingelheim
OXFORD: Oxford Biomedica has signed a new three year Development & Supply Agreement (DSA) with Boehringer Ingelheim for the manufacture and supply of various types of viral vectors. Under the terms of the DSA, Oxford Biomedica intends to manufacture GMP…